SEC Form 4 · accession 0001206774-16-004213
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary G Gemignani
Officer — Chief Financial Officer
Period of report
Jan 21, 2016
Accepted (ET)
Jan 25, 2016 · 8:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.26 | Jan 21, 2016 | A | 600,000 | A | — | Jan 20, 2023 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1This option vests over three years in equal, quarterly, installments.